GlassScriptPhysician profile
Preethi Durgam
NPI 1982929253
$7,786.42
in general payments reported to CMS, 2019-2025
49 companies · $2,686 in 2025
The $2,686 reported for 2025 was more than what 77% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $46.08 · 2021: $222 · 2022: $1,070 · 2023: $1,575 · 2024: $2,079 · 2025: $2,686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,228 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,228.48 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $831.46 | 2024-2025 | Inspire |
| Abbvie INC. | $620.29 | 2021-2025 | Duopa, Ubrelvy, Qulipta |
| Novartis Pharmaceuticals Corporation | $539.05 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $501.75 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Neurocrine Biosciences, INC. | $470.89 | 2022-2025 | Ingrezza, Ongentys |
| Sk Life Science, INC. | $451.13 | 2022-2025 | |
| Emd Serono, INC. | $366.95 | 2022-2025 | Mavenclad |
| Jazz Pharmaceuticals INC. | $337.52 | 2019-2025 | Epidiolex |
| Pfizer INC. | $290.67 | 2023-2025 | |
| Lundbeck LLC | $244.97 | 2024-2025 | Rexulti, Vyepti |
| Biogen, INC. | $214.86 | 2020-2025 | Vumerity, Tysabri |
| Celgene Corporation | $204.28 | 2022-2025 | Zeposia |
| Genentech USA, INC. | $197.89 | 2019-2025 | Ocrevus Zunovo, Ocrevus, Activase |
| Eisai INC. | $196.78 | 2023-2025 | |
| Axsome Therapeutics, INC. | $191.18 | 2023-2025 | Sunosi, Symbravo |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $188.70 | 2022-2025 | Wakix |
| Argenx US, INC. | $153.24 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Acadia Pharmaceuticals INC | $148.57 | 2023-2025 | Nuplazid |
| Alexion Pharmaceuticals, INC. | $139.16 | 2024-2025 | Ultomiris |
| Biohaven Pharmaceutical Holding Company LTD. | $135.27 | 2022 | |
| Lilly USA, LLC | $124.82 | 2024-2025 | Kisunla, Amyvid, Emgality |
| Abbott Laboratories | $106.53 | 2023-2025 | Infinity, Eterna |
| Aucta Pharmaceuticals, INC. | $98.25 | 2024-2025 | Motpoly Xr |
| Livanova USA, INC. | $89.05 | 2024-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Astrazeneca Pharmaceuticals LP | $71.77 | 2021-2022 | |
| Medtronic, INC. | $67.56 | 2022-2025 | Activa PC |
| Amgen INC. | $64.45 | 2023-2025 | Uplizna, Aimovig |
| Ucb, INC. | $63.21 | 2023-2025 | Rystiggo, Fintepla |
| Amneal Pharmaceuticals LLC | $63.11 | 2022-2025 | Rytary, Crexont |
| Azurity Pharmaceuticals, INC. | $62.52 | 2023-2025 | Horizant, Horizant |
| Avadel Cns Pharmaceuticals, LLC | $62.51 | 2024-2025 | Lumryz |
| Janssen Pharmaceuticals, INC | $52.30 | 2022 | |
| Avion Pharmaceuticals | $44.78 | 2022-2023 | Dhivy |
| Grifols USA, LLC | $41.89 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.32 | 2025 | Hyqvia |
| Sunovion Pharmaceuticals INC. | $27.69 | 2022 | |
| Sumitomo Pharma America, INC. | $27.20 | 2023-2024 | Aptiom |
| Life Molecular Imaging LTD | $24.82 | 2025 | Neuraceq |
| 3b Medical, INC. | $24.79 | 2025 | Luna |
| Csl Behring | $23.82 | 2025 | Hizentra |
| Corium, LLC | $23.27 | 2023 | Adlarity |
| Vanda Pharmaceuticals INC. | $22.80 | 2024 | Ponvory |
| Banner Life Sciences, LLC | $22.13 | 2022 | |
| Philips North America LLC | $21.95 | 2025 | Home Pi Undivided |
| Otsuka America Pharmaceutical, INC. | $21.65 | 2025 | Rexulti |
| Zoll Respicardia, INC. | $21.55 | 2023 | Remede System |
| Bio Products Laboratory USA, INC. | $19.90 | 2023 | Gammaplex, Coagadex |
| Idorsia Pharmaceuticals US INC | $19.00 | 2024 | Quviviq |
| Tanabe Pharma America, INC. | $18.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preethi Durgam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.